Skip to main content
An official website of the United States government

Research Highlights - News Updates

Highlighted research findings and scientific papers by DCEG investigators.
    • Germline-Somatic Interactions, Telomere Biology Affect Myelofibrosis Risk
      , by Jennifer K. Loukissas, M.P.P.

      DCEG investigators have identified six germline susceptibility loci for the rare myeloproliferative neoplasm (MPN) myelofibrosis; four overlap with loci previously identified for overall MPN. The findings were published September 8, 2022, in Nature Communications.

      Continue Reading >

    • Inaugural Intramural Health Disparities Workshop
      , by Jennifer K. Loukissas, M.P.P.

      The Center for Cancer Research Health Disparity Steering Committee, DCEG Cancer Health Disparities Working Group, and Fellows Cancer Health Disparities Interest Group co-organized a workshop to communicate expectations of health disparity research, identify research resources, highlight opportunities for collaborations, and outline future directions.

      Continue Reading >

    • Early HPV Vaccination is Important in Reducing HPV 16/18 Prevalence
      , by Elise Tookmanian, Ph.D.

      Using NHANES data, DCEG researchers found that HPV vaccination before sexual debut virtually eliminated HPV 16/18 in females but vaccination after debut only reduced HPV-16/18 prevalence by 40 percent compared to those unvaccinated. Only 59 percent of U.S. childhood HPV vaccinations occurred before sexual debut.

      Continue Reading >

    • Tobacco Smoke at Home Linked To Higher Mortality Across Diverse Group of Nonsmokers
      , by Elise Tookmanian, Ph.D.

      Nonsmokers exposed daily to environmental tobacco smoke (ETS) at home had higher mortality risks than those unexposed in a nationally representative study of the US population. These findings were observed across population subgroups of race and ethnicity, education, and household income, according to a study led by Dr. Daniela Gutiérrez in the Metabolic Epidemiology Branch.

      Continue Reading >

    • Largest GWAS Maps Variation in Human Height
      , by Jennifer Loukissas, M.P.P.

      The international consortium known as GIANT published results from the largest-known genome-wide association study (GWAS)—nearly 5.4 million people—and identified more than 12,000 genetic variants associated with variation in human height. Dr. Sonja Berndt played a major role in the study. These findings were published in Nature on October 12, 2022.

      Continue Reading >

    • Novel Potential Risk Factors Identified for Treatment-Related Thoracic Soft-Tissue Sarcomas
      , by Jennifer Loukissas, M.P.P.

      Drs. Lene Veiga and Amy Berrington in the Radiation Epidemiology Branch explored the risk of thoracic soft tissue sarcomas among breast cancer survivors in two U.S. cohorts. They identified a history of hypertension or diabetes as novel potential co-factors for radiation-induced angiosarcoma.

      Continue Reading >

    • Despite Recent Declines, Gastric Cancer Remains Leading Cause of Cancer Death in the Americas
      , by Jennifer K. Loukissas, M.P.P.

      Drs. Constanza Camargo, Christian Alvarez, and collaborators in Brazil, Peru, Mexico, and Spain, analyzed data from the NCI Surveillance, Epidemiology, and End Results Program and the World Health Organization to provide the most up-to-date estimates on gastric cancer mortality trends at a country-specific level for Hispanic/Latino populations. Patterns differed by country, sex, and age, revealing potential for prevention.

      Continue Reading >

    • Increased Meningioma Risk Following Treatments for Childhood Cancer
      , by Elise Tookmanian, Ph.D.

      In the largest pooled study of childhood cancer survivors to date, Dr. Lene Veiga in the Radiation Epidemiology Branch and former fellow Dr. Diana Withrow, observed that meningioma risk increased linearly with the treatment radiation dose. Meningioma risk was higher for children treated before age 10 and persisted over 30 years after radiotherapy. Receiving the chemotherapy drug, methotrexate was also associated with increased risk of meningioma, but no dose-response relationship was observed.

      Continue Reading >

    • A Healthy Lifestyle May Help Former Smokers Lower Their Risk of Death from All Causes
      , by NCI Staff

      Findings from an analysis of a large group of former smokers who participated in the NIH-AARP Diet and Health Study showed that former smokers who adhered to evidence-based recommendations for body weight, physical activity, and alcohol intake had a lower risk of mortality than former smokers who didn't adhere to these recommendations.

      Continue Reading >

    • Tea Consumption Associated with Lower Risk of Death

      Investigators found that drinking 2+ cups of tea per day was associated with lower risk of death in a study of nearly five million people in the United Kingdom, where black tea is common.

      Continue Reading >

    • Many Types of Leisure Time Activities May Lower Risk of Death for Older Adults
      , by NCI Staff

      A study led by Dr. Eleanor Watts showed that older adults who participate weekly in many different types of leisure time activities, such as walking for exercise, jogging, swimming laps, or playing tennis, may have a lower risk of death from any cause, as well as death from cardiovascular disease and cancer.

      Continue Reading >

    • HPV Vaccine Protection Outweighs Additional Risk of Cervical Lesions Caused by Non-Preventable HPV Types
      , by Maura Kate Costello, M.A.

      In a study published June 2022 in Lancet Oncology, Jaimie Shing, Ph.D., M.P.H., and colleagues observed that HPV types not targeted by the vaccine cause cervical lesions more frequently in vaccinated populations than in unvaccinated populations. However, the number of prevented cervical lesions was considerably greater than the number of additional lesions attributed to non-preventable HPV types, thus confirming the efficacy of the HPV vaccine for cervical cancer prevention.

      this study is the first to observe and evaluate clinical unmasking following HPV vaccination.  

      Continue Reading >

    • Oral Microbiome Linked to Lung Cancer Risk
      , by Elise Tookmanian, Ph.D.

      A study from Emily Vogtmann, Ph.D., M.P.H., senior investigator in the Metabolic Epidemiology Branch, links the oral microbiome to lung cancer risk using data from three DCEG cohorts: the Agricultural Health Study, NIH-AARP Diet and Health Study, and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial.

      Continue Reading >

    • Testing for IBMFS Important for Treatment Decisions in Severe Aplastic Anemia
      , by Jennifer K. Loukissas, M.P.P.

      Individuals who receive hematopoietic cell transplant (HCT) for treatment of severe aplastic anemia (SAA) can benefit from genetic testing prior to treatment initiation to determine if they have an unrecognized inherited bone marrow failure syndrome.

      Continue Reading >

    • Interferon Treatment May Improve COVID-19 Outcomes in People with Certain Genetic Factors
      , by Justine E. Yu, Ph.D.

      Drs. Ludmila Prokunina-Olsson, Oscar Florez-Vargas, and Rouf Banday in the Laboratory of Translational Genomics investigated the role of OAS1 in COVID-19 severity in patients of European and African ancestries. This finding contributes to the understanding of the molecular mechanisms of COVID-19 disease severity and may inform treatment options for COVID-19.

      Continue Reading >

    • Bringing the Pieces Together: CCR-DCEG FLEX Awards
      , by Elise Tookmanian, Ph.D.

      To capitalize on the complementary research approaches of the Center for Cancer Research (CCR) and DCEG, the CCR-DCEG FLEX award was established in 2015 to fund collaborative projects. Seven years later, Drs. Constanza Camargo, Charles Rabkin, Eric Engels, Neelam Giri, and Laufey Amundadottir, discuss how their projects came about and their progress toward understanding the causes of cancer and the means of prevention.

      Continue Reading >

    • Validation of a Low-cost, Rapid HPV DNA Genotyping Test for Cervical Cancer Prevention
      , by Jennifer K. Loukissas, M.P.P.

      A key deliverable of the Cancer Moonshot initiative to Accelerate Cervical Cancer Control is a rapid, mobile, simple, and affordable HPV DNA typing assay for risk-based screening and management in resource-limited settings where routine screening is logistically and cost prohibitive. Drs. Kanan Desai, Mark Schiffman, Silvia de Sanjose, and colleagues in the Clinical Epidemiology Unit, Clinical Genetics Branch, in cooperation with Atila Biosystems scientists, guided the redesign of an existing test for this purpose.

      Continue Reading >

    • Radioactive Iodine Treatment for Thyroid Cancer Associated with Increased Risk of Second Cancers
      , by Maura Kate Costello, M.A.

      Elisa Pasqual, M.D., Ph.D., and colleagues found that RAI therapy for thyroid cancer among people younger than 45 was associated with increased risk of solid cancer and leukemia. The strength of this study lies in its size and length of follow up.

      Continue Reading >

    • Two Studies on Disinfection Byproducts in Drinking Water and Cancer Risk
      , by Elise Tookmanian, Ph.D.

      Two studies from the Occupational and Environmental Epidemiology Branch, led by Drs. Laura Beane Freeman and Rena Jones, respectively, investigated the relationship between disinfection byproducts in drinking water and genetic factors for risk for bladder cancer and hormonal factors and risk for endometrial cancer.

      Continue Reading >

    • Cancer Death Rates Among Black People Declined Over Time, but Remain Higher than Other Racial and Ethnic Groups
      , by NCI Staff

      Wayne Lawrence, Dr.Ph.H., postdoctoral fellow in the Metabolic Epidemiology Branch, and Meredith Shiels, Ph.D., senior investigator in the Infections and Immunoepidemiology Branch report that from 1999 to 2019, rates of cancer deaths declined steadily among Black people in the United States. Nevertheless, in 2019, Black people still had considerably higher rates of cancer death than people in other racial and ethnic groups.

      Continue Reading >

Email